References
Bartkova, J.; Lukas, J.; Müller, H., et al. Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer 57:353–361; 1994.
Bronner, M. P.; Culin, C.; Reed, J. C., et al. The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. Am. J. Pathol. 146:20–26; 1995.
Buckley, M. F.; Sweeney, K. J. E.; Hamilton, J. A., et al. Expression and amplification of cyclin genes in human breast cancer. Oncogene 8:2127–2133; 1993.
Calaf, G.; Russo, J. Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis 14:483–492; 1993.
Chan, W. K.; Poulsom, R.; Lu, Q. L., et al. Bcl-2 expression in invasive mammary carcinoma: correlation with apoptosis, hormone receptors and p53 expression. J. Pathol. 169:153A; 1993.
Chang, S. E. In vitro transformation of human epithelial cells. Biochim. Biophys. Acta 823:161–194; 1986.
DiPaolo, J. A. Relative difficulties in transforming human and animal cells in vitro. J. Natl. Cancer Inst. 70:3–8; 1983.
Doll, R. An epidemiological perspective of the biology of cancer. Cancer Res. 38:3573–3583; 1978.
Farber, E. The multistep nature of cancer development. Cancer Res. 44:4217–4223; 1984.
Gee, J. M.; Robertson, J. F.; Ellis, I. O., et al. Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy. Int. J. Cancer 59:619–628; 1994.
Gillet, C.; Fantl, V.; Smith, R., et al. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res. 54:1812–1817; 1994.
Han, E. K. H.; Sgambato, A.; Jiang, W., et al. Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the Sphase and inhibits growth. Oncogene 10:953–961; 1995.
Hinds, P. W.; Dowdy, S. F.; Eaton, E. N., et al. Function of a human cyclin gene as an oncogene. Proc. Natl. Acad. Sci. USA 91:709–713; 1994.
Hockenbery, D.; Nunez, G.; Milliman, C., et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 349:334–336; 1990.
Lauwers, G. Y.; Scott, G. V.; Hendricks, J. Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia. Cancer 73:2900–2904; 1994.
Lu, P.J.; Lu, Q. L.; Rughetti, A., et al. Bcl-2 overexpression inhibits cell death and promotes the morphogenesis, but not tumorigenesis of human mammary epithelial cells. J. Cell Biol. 129:1363–1378; 1995.
Lynch, H. T.; Lynch, J. F. Breast cancer genetics in an oncology clinic: 328 consecutive patients. Cancer Genet. Cytogenet. 22:369–371; 1986.
Marcus, J. N.; Watson, P.; Page, D. L., et al. Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 77:697–709; 1996.
Marshall, E. Search for a killer: focus shifts from fat to hormones. Science 259:618–621; 1993.
McDonnell, T. J.; Deane, N.; Platt, F. M., et al. Bcl-2 immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57:79–88; 1989.
McDonnell, T.J.; Korsmeyer, S. J. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the 4(14:18). Nature 349:254–256; 1991.
Montesano, R.; Tomatis, L. Legislation concerning chemical carcinogens in several industrialized countries. Cancer Res. 37:310–316; 1977.
Motokura, T.; Bloom, T.; Kim, H. G., et al. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 350:512–515; 1991.
Musgrove, E. A.; Lee, C. S.; Buckley, M. F., et al. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc. Natl. Acad. Sci. USA 91:8022–8026; 1994.
Nakagawa, K.; Yamamura, K.; Maeda, S., et al. Bcl-2 expression in epidermal keratinocytic diseases. Cancer 74:1720–1724; 1994.
Nataraj, A.; Pathak, S.; Hopwood, V. L., et al. Bcl-2 oncogene blocks differentiation and extends viability but does not immortalize normal human keratinocytes. Int. J. Oncol. 4:1211–1218; 1994.
Putnam, D. L.; Park, D. K.; Rhim, J. S., et al. Correlation of cellular aggregation of transformed cells and their growth in soft agar and tumorigenic potential. Proc. Soc. Exp. Biol. Med. 155:487–494; 1977.
Reed, J. C.; Cuddy, M.; Haldar, S., et al. BCL2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL2 antisense. Proc. Natl. Acad. Sci. USA 87:3660–3664; 1990.
Russo, J.; Barnabas, N.; Zhang, P. L., et al. Molecular basis of breast cell transformation. Radiat. Oncol. Invest. 3:424–429; 1996.
Russo, J.; Calaf, G.; Sohi, N., et al. Critical steps in breast carcinogenesis. Ann. NY Acad. Sci. 698:1–20; 1993.
Russo, J.; Reina, D.; Frederick, J., et al. Expression of phenotypical changes by human breast epithelial cells treated with carcinogens in vitro. Cancer Res. 48:2837–2857; 1988.
Sabourin, J. C.; Martin, A.; Baruch, J., et al. Bcl-2 expression in normal breast tissue during the menstrual cycle. Int. J. Cancer 59:1–6; 1994.
Seidman, H.; Stellman, S. D.; Mushinski, M. H. A different perspective on breast cancer risk factors: some implications of the nonattributable risk. Ca Cancer J. Clin. 32:301–313; 1982.
Sherr, C. J. G1 phase progression: cycling on cue. Cell 79:551–555; 1994.
Stampfer, M. R.; Bartley, J. C. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. Proc. Natl. Acad. Sci. USA 82:2394–2398; 1984.
Stoll, B. A. Reducing breast cancer risk in women. Dordrecht, Netherlands: Kluwer Academic Publishers; 1995:3–9.
Traul, K. A.; Takayama, K.; Kachevsky, V., et al. A rapid in vitro assay for carcinogenicity of chemical substances in mammalian cells utilizing an attachment independence endpoint-2-assay validations. J. Appl. Toxicol. 1:190; 1981.
Tsujimoto, Y.; Croce, C. M. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA 83:5214–5218; 1986.
Weistat-Saslow, D.; Merino, M. J.; Richard, E. M., et al. Overexpression of cyclin D mRNA distinguish invasive and in situ breast carcinomas from non-malignant lesions. Nature Med. 1:1257–1260; 1995.
Zhang, S. Y.; Camano, J.; Cooper, F., et al. Immunohistochemistry of cyclin D1 in human breast cancer. Am. J. Clin. Pathol. 102:695–698; 1994.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hu, Y.F., Lynch, H.T., Russo, I.H. et al. Environmental chemical carcinogens induce transformation of breast epithelial cells from women with familial history of breast cancer. In Vitro Cell.Dev.Biol.-Animal 33, 495–498 (1997). https://doi.org/10.1007/s11626-997-0090-6
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11626-997-0090-6